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Soil-transmitted helminths (STH), a group of three intestinal worms are estimated to affect up to a 
billion people globally, predominantly in low-income settings. The world’s largest deworming 
program has been the lymphatic filariasis elimination programme, which provides community-wide 
treatment with treatments that also affect STH. As these programmes scale back due to successful 
control of lymphatic filariasis there is a question of whether, and how, to continue or expand 
deworming for STH, usually delivered through school-based deworming. 
 
Shifting from school-based to community deworming is an area of on-going debate. In this issue, 
Clarke et al. provide a review of empirical evidence on community-wide and child-targeted  
treatment strategies and show that treating adults in addition to children will have indirect benefits 
for children, particularly for roundworm [1]. This meta-analysis validates existing mathematical 
modelling [2] and cost-effectiveness analyses [3, 4] highlighting the potential benefits of expanding 
of STH control programmes to all age groups. However, questions remain about how to scale-up to 
mass treatment, and whether this would really allow programmes to become finite in their scope, 
meaning breaking transmission. There is also limited synthesis of available data on the potential role 
of water, sanitation and hygiene.  
 
Clarke et al’s meta-analysis [1] is an example of providing an explicit and transparent link between 
the policies being advocated and a reliable evidence base in a field where there has previously been  
some criticism [5]. We urgently need specific policy options guided by further reliable evidence base 
to support the long-term credibility and optimal implementation of STH control programmes.   For 
instance, the current study [1] and others have pleaded for properly conducted randomized 
controlled trials to address evidence gaps [6, 7, 5, 8]. Are we absolutely clear though about which 
anthelminthic drugs or which combinations of those to use in future trials and thus by extension in 
control programs?  Some conclusions about the superiority of some anthelminthic drugs over others 
have been drawn on mainly comparisons with placebo [7]. On the other hand, treatment networks 
to illustrate the types and numbers of treatments compared so far (so-called “geometry” of 
evidence) has also been provided for major neglected tropical diseases, highlighting the study of soil 
transmitted helminth infections through 160 trials, including 46,887 participants [6]. Recently a 
comparative appraisal of three broad-spectrum anthelmintic drug combinations on 440 children 
with a randomized controlled design has been applied for trichuriasis [8]. Can we not now evaluate 
all this evidence for each of these worms in the most adequate statistical way before we give exact 
recommendations for future clinical trials? The latter should not be designed as stand-alone 
experiments ignoring previous evidence. We should aim for minimum monetary and human cost 
involved and efficient future research planning. The use of network metanalysis [9] - a 
methodological tool which can include many competing treatments and make use of a wider 
evidence space by including direct and indirect comparisons could be a promising vehicle to answer 
some of these key questions. 
Furthermore, at the heart of current  debates are questions around the health impact of STH and 
whether the target of the global programme should be minimising morbidity in children through 
long-term deworming or breaking transmission [2]. Precise estimates for pathways from infection 
with STH to poor child development, as well as the mediating effects of nutrition and anaemia, are 
still lacking. Researchers in The Cochrane Collaboration reviewed the effects of school -
based deworming programmes on children’s health, ability to learn, and school attendance, through 
45 randomized trials, concluding non consistent benefits and highlighting very low, low or moderate 
quality of evidence [10]. Clarke et al [1], and others [11] stress  the risks of using imperfect 
diagnostic tools for the detection of STH  within research and  control.   Measurement error 
problems are highly pertinent in child development too; this construct  is complex, encompassing 
cognitive, sensorimotor and social‐emotional domains [12] and culturally appropriate child 
assessment instruments should be also considered in the design of future clinical trials as well as the 
collaborative involvement of endemic country mental health researchers and developmental 
psychologists in order to successfully overcome these challenges.   
 
There are signs that the evidence base for deworming is being strengthened, through evidence 
synthesis and fruitful debates. Continuing research will allow programs to move forward with well-
designed interventions to prevent STH infection and loss of human potential around the globe. 
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